March 28, 2018 / 5:06 AM / 2 months ago

BRIEF-Kiadis Pharma On Track With European Regulatory Review For ATIR101

March 28 (Reuters) - KIADIS PHARMA NV:

* ON TRACK WITH EUROPEAN REGULATORY REVIEW FOR ATIR101

* ‍ON TRACK TO POTENTIALLY OBTAIN A POSITIVE CHMP OPINION FOR ATIR101 IN Q4 2018

* ‍ON TRACK TO POTENTIALLY OBTAIN (CONDITIONAL) APPROVAL FROM EUROPEAN COMMISSION IN Q1 2019 FOR ATIR101​

* THE APPROVALS ‍WOULD ALLOW FOR A EUROPEAN LAUNCH IN H2 2019​

* ‍IS CONDUCTING A PHASE 3 TRIAL WITH ATIR101 ACROSS EUROPE AND NORTH AMERICA​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below